Results 101 to 110 of about 3,285,062 (216)

The application of ursodeoxycholic acid in patients with metabolic syndrome

open access: yes, 2014
The aim of the study was to determine the efficacy of ursodeoxycholic acid (UDCA) in patients with ...
Krivonosova, Elena, Adeyemi, Aleksander
core  

Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration

open access: yes, 1998
An exceptional case of early onset and prolonged postpartum course of intrahepatic cholestasis of pregnancy is described. Contrary to other drugs tested, ursodeoxycholic acid administered after the 29th week of gestation improved pruritus and decreased ...
Rodrigues, Cecília M. P.   +7 more
core   +1 more source

Indoleamine 2,3‐Dioxygenase 1 as an Adjunctive Histopathological Marker of Cholangitis Activity in Primary Biliary Cholangitis

open access: yesHepatology Research, EarlyView.
IDO‐1 immunostaining identifies primary biliary cholangitis even in morphologically subtle bile duct lesions. IDO‐1 expression reflects cholangitis activity and is suppressed by ursodeoxycholic acid treatment, indicating its value as a dynamic diagnostic adjunct rather than a static marker of chronic damage.
Kaori Yoshimura   +10 more
wiley   +1 more source

Primary Biliary Cholangitis Unmasked in Metabolic Dysfunction‐Associated Steatohepatitis: When a Correct Diagnosis Is Incomplete

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yucheng Cheng   +3 more
wiley   +1 more source

Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor‐Induced Liver Injury

open access: yesHepatology Research, EarlyView.
Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...
Naoto Soma   +7 more
wiley   +1 more source

Appearance of a gallstone in a patient with systemic lupus erythematosus during ursodeoxycholic acid treatment [letter]

open access: yes, 1993
Appearance of a gallstone in a patient with systemic lupus erythematosus during ursodeoxycholic acid treatment ...
A. Carletto   +5 more
core   +1 more source

Epigenomic Cascades Across Organs in Metabolic Dysfunction–Associated Steatotic Liver Disease: New Therapeutic Horizons

open access: yesObesity Reviews, EarlyView.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide, affecting approximately one‐third of the population and increasing the risk of severe hepatic and cardiovascular complications.
Shurui Yang   +4 more
wiley   +1 more source

A contribution to the complexation of ursodeoxycholic acid with beta-cyclodextrin

open access: yes, 1995
A contribution to the complexation of ursodeoxycholic acid with beta-cyclodextrin is ...
VANDELLI, Maria Angela   +4 more
core  

Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones [PDF]

open access: yes, 1989
The high rate of stone recurrence represents a drawback of non-surgical therapy of cholesterol gallstone disease. Although most studies report that long-term bile acid treatment does not have protective effects, preliminary results suggest that low-dose ...
Paumgartner, Gustav   +3 more
core   +1 more source

Effect of Ursodeoxycholic Acid Alone Verses Ursodeoxycholic Acid and Rifampicin in Obstetric Cholestasis

open access: yesPakistan Journal of Medicine and Dentistry
Background: Intrahepatic cholestasis of pregnancy (ICP) is a common liver disorder in pregnancy, associated with pruritus, elevated bile acids, and increased risk of adverse perinatal outcomes.
Ayesha Amjad   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy